Price premium was 20% on 62% fe Pilbara fines blend for a 68% ish blend but the index is no longer published so they are in discussion to determine a new pricing index
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%